1. Home
  2. MTNB vs SHFS Comparison

MTNB vs SHFS Comparison

Compare MTNB & SHFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MTNB
  • SHFS
  • Stock Information
  • Founded
  • MTNB 2013
  • SHFS 2015
  • Country
  • MTNB United States
  • SHFS United States
  • Employees
  • MTNB N/A
  • SHFS N/A
  • Industry
  • MTNB Biotechnology: Pharmaceutical Preparations
  • SHFS Finance: Consumer Services
  • Sector
  • MTNB Health Care
  • SHFS Finance
  • Exchange
  • MTNB Nasdaq
  • SHFS Nasdaq
  • Market Cap
  • MTNB 5.2M
  • SHFS 6.3M
  • IPO Year
  • MTNB N/A
  • SHFS N/A
  • Fundamental
  • Price
  • MTNB $0.93
  • SHFS $3.27
  • Analyst Decision
  • MTNB Hold
  • SHFS
  • Analyst Count
  • MTNB 1
  • SHFS 0
  • Target Price
  • MTNB N/A
  • SHFS N/A
  • AVG Volume (30 Days)
  • MTNB 52.1K
  • SHFS 44.6K
  • Earning Date
  • MTNB 08-13-2025
  • SHFS 08-13-2025
  • Dividend Yield
  • MTNB N/A
  • SHFS N/A
  • EPS Growth
  • MTNB N/A
  • SHFS N/A
  • EPS
  • MTNB N/A
  • SHFS N/A
  • Revenue
  • MTNB N/A
  • SHFS $13,956,453.00
  • Revenue This Year
  • MTNB N/A
  • SHFS N/A
  • Revenue Next Year
  • MTNB N/A
  • SHFS N/A
  • P/E Ratio
  • MTNB N/A
  • SHFS N/A
  • Revenue Growth
  • MTNB N/A
  • SHFS N/A
  • 52 Week Low
  • MTNB $0.47
  • SHFS $1.84
  • 52 Week High
  • MTNB $8.75
  • SHFS $13.80
  • Technical
  • Relative Strength Index (RSI)
  • MTNB 48.75
  • SHFS 57.11
  • Support Level
  • MTNB $0.94
  • SHFS $3.01
  • Resistance Level
  • MTNB $1.04
  • SHFS $3.58
  • Average True Range (ATR)
  • MTNB 0.07
  • SHFS 0.49
  • MACD
  • MTNB -0.01
  • SHFS 0.01
  • Stochastic Oscillator
  • MTNB 20.07
  • SHFS 64.51

About MTNB Matinas Biopharma Holdings Inc.

Matinas BioPharma Holdings Inc is a clinical-stage biopharmaceutical company with a focus on identifying and developing novel pharmaceutical products. The firm's pipeline includes MAT2203, MAT2501, and others.

About SHFS SHF Holdings Inc.

SHF Holdings Inc is a financial services provider to cannabis-related businesses. It offers reliable access to banking solutions for cannabis, hemp, CBD, and ancillary operators, making communities safer, driving growth in local economies, and fostering long-term partnerships. The group, through its financial institution clients, implements accountability, transparency, monitoring, reporting, and risk mitigation measures while meeting Bank Secrecy Act obligations in line with FinCEN guidance on cannabis-related businesses. Its services include Program Management Support, Customer Generation, Ongoing Program Auditing, and Compliance Monitoring, among others.

Share on Social Networks: